Citius Pharmaceuticals, Inc. Financial Ratios — CTXR Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-12,683.57	-46,472.59	- -	-252.48	-73.12	-44.79	-45.2	-45.91	-43.59	-24.76	-26.24	-29.91	-35.54	-30.24
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Total Debt	- -	- -	- -	1	- -	1	- -	- -	- -	1	1	1	- -	- -	2
ST Debt	- -	- -	- -	1	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	1
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -	- -	1
Total Debt/EBITDA	-0.72	-1.97	-0.11	- -	- -	-0.09	-0.02	-0.01	-0.01	-0.08	-0.04	-0.02	-0.01	-0.01	-0.05
Net Debt/EBITDA	-0.71	-1.97	-0.11	- -	0.21	-0.05	0.3	0.65	0.5	0.77	3	1.26	0.72	0.08	0.08
Total Debt/EBIT	-0.72	-1.97	-0.11	- -	- -	-0.09	-0.02	-0.01	-0.01	-0.08	-0.04	-0.02	-0.01	-0.01	-0.05
Net Debt/EBIT	-0.71	-1.97	-0.11	- -	0.21	-0.05	0.3	0.65	0.49	0.76	2.98	1.25	0.72	0.08	0.08
EBITDA to Interest Expense	-36.42	-8.22	-8.65	- -	-430.66	-828.1	-11.73	-870.53	-948.58	-1,120.29	-2,155.83	- -	- -	- -	-143.07
EBITDA-CapEx/Interest Expense	-36.42	-8.22	-8.65	- -	-430.66	-828.1	-11.74	-870.53	-948.58	-1,120.41	-5,846.85	- -	- -	- -	-143.07
EBIT to Interest Expense	-36.42	-8.22	-8.65	- -	-430.66	-828.25	-11.74	-870.64	-948.63	-1,130.01	-2,171.04	- -	- -	- -	-143.87
Interest Expense	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-11,245.75	-33,960.74	- -	-392.19	-1,214.56	-78.96	-113.5	-129.6	-144.28	-161.14	-67.33	-113.63	-156.57	-172.62	-182.37
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.03	0.51	0.47	0.29	0.03	0.94
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1.47	-0.72	-0.38	-0.16	-0.01	-0.32
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.33	0.48	0.42	0.25	0.02	0.55
Total Debt/Equity (%)	-77.57	-84.5	-21.84	-80.87	- -	4.01	0.79	0.62	0.64	4.02	0.64	0.66	0.53	0.35	2.34
Total Debt/Capital (%)	-345.79	-545.1	-4.34	-10.89	- -	-4.04	-0.63	-0.43	-0.33	-1.95	-0.91	-0.53	-0.3	-0.13	-0.8
Total Debt/Total Assets (%)	8,723.11	28,696.3	- -	38.52	- -	3.07	0.71	0.56	0.47	3.09	0.6	0.59	0.46	0.23	1.38
Net Debt to Equity	-76.68	-84.2	-21.84	128.32	106.44	2.26	-13.81	-32.34	-28.43	-40.16	-52.77	-40.33	-28.96	-4.39	-4.2
Net Debt/Capital (%)	-328.79	-533.07	-4.34	13.48	6.98	-2.23	9.86	18.3	12.71	16.28	42.59	24.54	14.11	1.62	1.41
EBITDA	- -	- -	- -	- -	-3	-7	-10	-14	-16	-18	-23	-33	-37	-42	-38
EBITDA-CapEx	- -	- -	- -	- -	-3	-7	-10	-14	-16	-18	-63	-33	-37	-42	-38
Operating Income (Loss)	- -	- -	- -	- -	-3	-7	-10	-14	-16	-18	-24	-33	-37	-42	-39

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Cash Ratio	0.01	- -	- -	0.67	0.49	0.06	1.3	2.88	1.71	3.38	17.6	9.21	4.58	0.09	0.09
Current Ratio	0.01	- -	- -	0.67	0.53	0.17	1.39	3.16	1.72	3.41	18.28	9.84	5.95	0.4	0.62
Quick Ratio	0.01	- -	- -	0.67	0.49	0.06	1.3	3.14	1.71	3.38	17.6	9.21	4.58	0.09	0.09
CFO/Avg Current Liab	- -	-0.58	-0.68	- -	-1.3	-1.8	-2.08	-4	-3.19	-3.89	-6	-6.66	-5.64	-1.36	-0.66
Common Equity/Total Assets	-11,245.75	-33,960.74	- -	-392.19	-1,214.56	-78.96	-113.5	-129.6	-144.28	-161.14	-67.33	-113.63	-156.57	-172.62	-182.37
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.03	0.51	0.47	0.29	0.03	0.94
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1.47	-0.72	-0.38	-0.16	-0.01	-0.32
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.33	0.48	0.42	0.25	0.02	0.55
Total Debt/Equity (%)	-77.57	-84.5	-21.84	-80.87	- -	4.01	0.79	0.62	0.64	4.02	0.64	0.66	0.53	0.35	2.34
Total Debt/Capital (%)	-345.79	-545.1	-4.34	-10.89	- -	-4.04	-0.63	-0.43	-0.33	-1.95	-0.91	-0.53	-0.3	-0.13	-0.8
Total Debt/Total Assets (%)	8,723.11	28,696.3	- -	38.52	- -	3.07	0.71	0.56	0.47	3.09	0.6	0.59	0.46	0.23	1.38
CFO/Total Liabilities	-86.4	-44.2	-140.22	- -	-173.26	-113.82	-322.83	-355.38	-129.65	-167.58	-251.4	-268.24	-238.6	-66.28	-49.71
CFO/CapEx	- -	- -	- -	- -	- -	- -	-3,749.39	- -	- -	-9,246.67	-0.61	- -	- -	- -	- -
Altman's Z-Score	-810.32	-1,549.2	- -	-6.11	-9.13	-52.09	-16.39	-5.84	-14.26	-7.26	11.95	4.65	-3.91	-29.59	-16.58

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.11	1.51
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	173.36	242.43
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8	22
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	12
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6	11
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Market Capitalization	- -	- -	- -	- -	54	34	17	18	15	41	220	177	104	84	14
- Cash & Cash Equivalents	- -	- -	- -	2	1	- -	3	9	8	14	70	42	26	3	4
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	4	10
+ Total Debt	- -	- -	- -	1	- -	1	- -	- -	- -	1	1	1	- -	- -	2
Enterprise Value	- -	- -	- -	-1	53	35	14	9	8	28	152	136	78	85	21
Total Capital	- -	- -	- -	-6	-9	-17	-28	-40	-53	-69	-94	-128	-161	-197	-227
Total Debt/Capital (%)	-345.79	-545.1	-4.34	-10.89	- -	-4.04	-0.63	-0.43	-0.33	-1.95	-0.91	-0.53	-0.3	-0.13	-0.8
Total Debt / EV	1.01	1	1	-0.63	- -	0.02	0.01	0.02	0.02	0.05	0.01	- -	0.01	- -	0.09
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.63	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	54	34	17	18	15	41	220	177	104	84	14
Diluted Enterprise Value	- -	- -	- -	-1	53	35	14	9	8	28	152	136	78	85	21
EV per Share	0.61	1.29	0.11	- -	629.54	238.74	65	21.76	9.37	18.02	34.95	23.33	12.91	12.67	1.92
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	- -	- -	- -	- -	-3	-7	-10	-14	-16	-18	-23	-33	-37	-42	-38
TTM Operating Income	- -	- -	- -	- -	-3	-7	-10	-14	-16	-18	-24	-33	-37	-42	-39
TTM Cash Flow to Firm	- -	- -	- -	- -	-2	-6	-7	-11	-12	-17	-24	-28	-29	-28	-26
TTM Free Cash Flow to Firm	- -	- -	- -	- -	-2	-6	-7	-11	-12	-17	16	-28	-29	-28	-26

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Price/Free Cash Flow	- -	- -	- -	- -	-22.69	-5.8	-2.17	-1.62	-1.23	-2.41	13.99	-6.23	-3.56	-2.99	-0.52
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	-1	53	35	14	9	8	28	152	136	78	85	21
Low Price	- -	- -	- -	- -	299.89	217.39	63.72	28	16.86	10	21.82	20.77	15.75	12	0.65
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	-16.13	-9.92	-3.58	-2.62	-1.53	-1.92	-8.3	-6.07	-5.24	-3.09	-0.85
Price/Earnings High	- -	- -	- -	- -	-21.94	-16.38	-7.84	-4.7	-3.26	-4.4	-21.48	-9.77	-7.95	-4.6	-3.8
Price/Earnings Low	- -	- -	- -	- -	-8.77	-3.8	-1.35	-0.96	-0.87	-0.89	-4.11	-3.61	-2.93	-2.06	-0.19
Price/Book Value	- -	- -	- -	- -	-6.01	-1.97	-0.62	-0.46	-0.29	-0.58	-2.3	-1.36	-0.64	-0.42	-0.06
Price/Book Value Average	- -	- -	- -	- -	-5.2	-4.75	-1.34	-0.82	-0.45	-0.48	-1.99	-1.58	-1.05	-0.6	-0.13
Price/Book Value High	- -	- -	- -	- -	-7.07	-7.84	-2.94	-1.46	-0.96	-1.09	-5.16	-2.54	-1.59	-0.89	-0.59
Price/Book Value Low	- -	- -	- -	- -	-2.83	-1.82	-0.5	-0.3	-0.26	-0.22	-0.99	-0.94	-0.59	-0.4	-0.03
Price/Tangible Book Value	- -	- -	- -	- -	-84.48	-8.11	17.99	2.67	-9.58	8.27	3.44	5.1	4.56	-3	-0.56
Price/Tangible Book Value Average	- -	- -	- -	- -	-73.08	-19.49	38.7	4.77	-14.98	6.83	2.99	5.89	7.52	-4.31	-1.3
Price/Tangible Book Value High	- -	- -	- -	- -	-99.39	-32.19	84.71	8.57	-31.88	15.67	7.73	9.48	11.4	-6.42	-5.77
Price/Tangible Book Value Low	- -	- -	- -	- -	-39.74	-7.47	14.55	1.75	-8.53	3.18	1.48	3.5	4.2	-2.88	-0.29
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	-22.69	-5.8	-2.17	-1.62	-1.23	-2.41	-9.09	-6.23	-3.56	-2.99	-0.52
Price/Cash Flow Average	- -	- -	- -	- -	-19.63	-13.94	-4.66	-2.9	-1.92	-1.99	-7.89	-7.2	-5.87	-4.29	-1.2
Price/Cash Flow High	- -	- -	- -	- -	-26.69	-23.03	-10.21	-5.21	-4.08	-4.56	-20.42	-11.59	-8.9	-6.38	-5.35
Price/Cash Flow Low	- -	- -	- -	- -	-10.67	-5.34	-1.75	-1.06	-1.09	-0.93	-3.91	-4.28	-3.28	-2.86	-0.27
Price/Free Cash Flow Average	- -	- -	- -	- -	-19.63	-13.94	-4.66	-2.9	-1.92	-1.99	12.14	-7.2	-5.87	-4.29	-1.2
Price/Free Cash Flow High	- -	- -	- -	- -	-26.69	-23.03	-10.21	-5.21	-4.08	-4.56	31.43	-11.59	-8.9	-6.38	-5.35
Price/Free Cash Flow Low	- -	- -	- -	- -	-10.67	-5.34	-1.75	-1.06	-1.09	-0.93	6.02	-4.28	-3.28	-2.86	-0.27
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-0.71	-1.97	-0.11	- -	-14.29	-11.1	-3.42	-1.73	-1.04	-1.2	-5.25	-4.95	-3.97	-2.92	-1.03
EV/EBITDA High	-0.71	-1.97	-0.11	- -	-19.5	-18.29	-7.85	-3.62	-2.76	-3.68	-18.26	-8.7	-6.39	-4.33	-3.91
EV/EBITDA Low	-0.71	-1.97	-0.11	- -	-7.67	-4.28	-1.1	-0.22	-0.38	-0.18	-1.12	-2.44	-1.91	-1.96	-0.38
EV/EBIT Average	-0.71	-1.97	-0.11	- -	-14.29	-11.09	-3.42	-1.73	-1.04	-1.19	-5.21	-4.92	-3.95	-2.91	-1.02
EV/EBIT High	-0.71	-1.97	-0.11	- -	-19.5	-18.29	-7.84	-3.62	-2.76	-3.65	-18.13	-8.65	-6.35	-4.31	-3.88
EV/EBIT Low	-0.71	-1.97	-0.11	- -	-7.67	-4.28	-1.1	-0.22	-0.38	-0.18	-1.11	-2.43	-1.9	-1.95	-0.38
Last Price	- -	- -	- -	- -	637.5	236.13	78.82	42.75	18.94	26	50.75	30.25	17.11	12.52	1.24
High Price	- -	- -	- -	- -	750	937.5	371.06	137.25	63	49.25	114	56.25	42.75	26.75	12.84
Enterprise Value Average	- -	- -	- -	-1	46	83	34	24	16	21	123	164	145	122	39
Enterprise Value High	- -	- -	- -	-1	63	136	78	50	43	65	427	288	233	181	150
Enterprise Value Low	- -	- -	- -	-1	25	32	11	3	6	3	26	81	70	82	15

Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	1	1	2	6	6	6	7	18
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	1	2	4	6	6	7	11
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	1	2	4	6	6	7	11
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-0.85	-0.65	-0.94	- -	-38.05	-51.39	-45.53	-32.12	-19.34	-11.21	-5.38	-5.67	-6.04	-6.21	-3.46
Operating Income per Share	-0.85	-0.65	-0.94	- -	-38.05	-51.4	-45.54	-32.12	-19.34	-11.31	-5.42	-5.7	-6.07	-6.24	-3.48
Basic EPS, GAAP	-0.88	-0.73	-1.05	- -	-34.19	-57.24	-47.36	-29.2	-19.3	-11.2	-5.31	-5.76	-5.38	-5.82	-3.38
Basic EPS from Cont Ops	-0.88	-0.73	-1.05	- -	-34.19	-57.24	-47.36	-29.2	-19.3	-11.2	-5.31	-5.76	-5.38	-5.86	-3.59
Diluted EPS, GAAP	-0.88	-0.73	-1.05	- -	-34.19	-57.24	-47.36	-29.2	-19.3	-11.2	-5.31	-5.76	-5.38	-5.82	-3.38
Diluted EPS from Cont Ops	-0.88	-0.73	-1.05	- -	-34.19	-57.24	-47.36	-29.2	-19.3	-11.2	-5.31	-5.76	-5.38	-5.86	-3.59
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.69	-0.68	-0.69	- -	-28.1	-40.71	-36.35	-26.37	-15.42	-10.81	-5.58	-4.85	-4.8	-4.19	-2.4
Free Cash Flow per Basic Share	-0.69	-0.68	-0.69	- -	-28.1	-40.71	-36.36	-26.37	-15.42	-10.81	-14.79	-4.85	-4.8	-4.19	-2.4
Cash & Equivalents per Share	0.01	- -	- -	- -	7.96	2.03	14.61	21.39	9.79	8.85	16.13	7.14	4.38	0.48	0.38
Book Value per Share	-0.79	-1.53	-2.57	- -	-106.09	-119.59	-126.37	-93.74	-65.74	-45.03	-22.08	-22.17	-26.81	-29.93	-21.58
Tangible Book Value per Share	-0.79	-1.53	-0.49	- -	-7.55	-29.12	4.38	16.02	-1.98	3.14	14.74	5.93	3.75	-4.17	-2.22

Citius Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)